ZALASTA

Tablet, 5mg
RxActive license

Active substance (INN)

olanzapine

Pharmaceutical form

Pharmaceutical formTablet
Strength5mg
PackagingUkupno 28 tableta u blisteru (4x7) u kartonskoj kutiji
ManufacturerKrka-Polska Sp. z o.o., Poland
Therapeutic groupNervous system (N05AH03)
Marketing authorization holderDIO STRANOG DRUŠTVA "KRKA D.D. NOVO MESTO" SLOVENIJA - PREDSTAVNIŠTVO PODGORICA
Authorization dateJuly 7, 2023

Analogs in Montenegro

5

Other medicines with the same active substance

ONZAPINRx
Film-coated tablet, 5 mgActavis Ltd.
ONZAPINRx
Film-coated tablet, 10mgActavis Ltd.
ONZAPINRx
Orodispersible tablet, 15mgActavis Ltd.
ONZAPINRx
Orodispersible tablet, 20mgActavis Ltd.
ZALASTARx
Tablet, 10mgKrka-Polska Sp. z o.o.
Source: CInMED register